Drug cuts bleeding risk in kidney stone surgery
NCT ID NCT07582341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving tranexamic acid, a drug that helps blood clot, through a vein and in surgical fluid can reduce bleeding during kidney stone removal. 90 adults with large kidney stones were randomly assigned to receive the drug or a placebo. The goal was to see if it lowers blood loss, improves the surgeon's view, and reduces the need for blood transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid
- What this could lead to
- If it works, this could make kidney stone surgery safer by reducing blood loss and the need for blood transfusions.
- What could go wrong
- This is a small, single-center study with 90 participants. Results may not apply to all patients, and tranexamic acid can rarely cause allergic reactions or blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benha University Hospital
Banhā, Qalyubia Governorate, 13511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A quick clotting test could make transfusions safer for children in surgery
- Which procedure wins for dense kidney stones?
- One cut or many? a surgical showdown for complex kidney stones
- Which kidney stone procedure works best for dense stones? a Head-to-Head trial
- New surgical tool aims to suck away kidney stones faster and safer
- Can changing how patients breathe make kidney stone surgery safer?